Preterm born babies often get a rough start in life due to their underdeveloped lungs. The Lund-based company Neola Medical wants to upgrade the care for these babies with their medicine technology device for continuous monitoring of the lungs. In the current rights issue, the company raises approximately 55MSEK to take the last step towards market launch.

Do not miss BioStock’s latest article about Neola Medical where the company, the medicine technology device Neola®, and the rights issue are presented.

Read the full article (in Swedish) here: BioStock – Emission ska ta Neola Medical fram till marknad